Luptakova Katarina — SEC Form 4 filings

SEC reporting owner CIK 1991149. 4 Form 4 filings on record with FilingPulse; latest filed 2026-01-05.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-05-03 to 2026-01-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Xilio Therapeutics, Inc. (XLO)CHIEF MEDICAL OFFICER418

Form 4 filings — Luptakova Katarina

FiledFormIssuerReported transactionsSource
2026-01-054Xilio Therapeutics, Inc. (XLO)Option exercise (M): 16,625 · Grant/award (A): 451,885 (derivative) @ $0 · Option exercise (M): 16,625 (derivative) @ $0EDGAR
2025-11-254Xilio Therapeutics, Inc. (XLO)Grant/award (A): 625,000 (derivative) @ $0 · Disposition to issuer (D): 44,210 (derivative) · Grant/award (A): 44,210 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Grant/award (A): 15,000 (derivative) · Disposition to issuer (D): 35,000 (derivative) · +5 moreEDGAR
2025-01-034Xilio Therapeutics, Inc. (XLO)Option exercise (M): 16,625 · Option exercise (M): 16,625 (derivative) @ $0 · Grant/award (A): 200,000 (derivative) @ $0EDGAR
2024-05-034Xilio Therapeutics, Inc. (XLO)Grant/award (A): 59,333 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1991149 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →